Immunopathology Lab

Rithvik completed his post graduation (M.S.) in Pharmaceutical Biotechnology from The National Institute of Pharmaceutical Education and Research (NIPER), Hajipur. He further carried out his masters dissertation at NIPER- Kolkata, wherein he worked to develop CRISPR-cas12a based diagnostic platform for detections of AMR strains. His current research is based on exploring novel pathological implications of IL-17/ IL-23 axis in psoriasis.

Gouri, holds a bachelors in biotechnology from KLE Technological Universtiy, Hubbali, where she has demonstrated expertise in cloning and bioanalytical techniques. Gouri, will begin her research by beginning to study the intricate role of fibroblast cells in the propagation of rheumatoid arthritis. 

Ashik completed his Doctor of Pharmacy (PharmD) from Rajiv Gandhi University of Health Sciences. Ashik pursued his internship at the Rajiv Gandhi Centre for Biotechnology (RGCB), where he worked in the Cancer Research and Synthetic Immunology Laboratories. His research primarily focused on developing model systems for CAR-T cell therapy. In addition, he possesses hands-on expertise in bispecific T cell engager (BiTE) development and CRISPR-Cas9.​

Anjali Kumari holds a Master’s degree in Biotechnology from DAV College and a Bachelor’s degree from Chandigarh University. Her M.Sc. research involved target validation of the drug Azstarys with the CDK2/Cyclin protein complex and evaluating its potential as a therapeutic candidate. She now aims to investigate the molecular mechanisms and therapeutic targets involved in autoimmune diseases.

Padmesh has a master’s degree in Biotechnology from Alagappa University. His master’s research focused on studying the anti-metastatic potential of farnesol in a 3D spheroid model of non-small cell lung cancer cells. His current research aims to decipher the molecular mechanisms of Majoon Ushba in IL-17 mediated psoriasis.

​Sivamano holds a Master's degree in Human Genetics and Molecular Biology from Bharathiar University and a Bachelor's degree in Microbiology. Her postgraduate research explored the role of CPLX2 in cervical cancer through integrative molecular and computational analyses. She will currently focus on identifying novel transcriptomic targets for therapeutic intervention in psoriasis.​